Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancer

ABSTRACT: This is an open-label, multicenter study to assess the safety, tolerability, pharmacokinetics, and antitumor activity of vactosertib in combination with pembrolizumab in patients with metastatic or locally advanced colorectal or gastric/gastroesophageal junction adenocarcinoma

DISEASE(S): Adenocarcinoma,Metastatic Colorectal Cancer,Gastroesophageal Junction Adenocarcinoma,Esophageal Neoplasms,Gastric Cancer,Stomach Neoplasms

PROVIDER: 2288267 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR